p21 is a transcriptional target of HOXA10 in differentiating myelomonocytic cells

  1. V. Carrie Bromleigh and
  2. Leonard P. Freedman1
  1. Cell Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA; Weill Medical College, Graduate School of Medical Sciences, Cornell University, New York, New York 10021, USA

Abstract

The myeolomonocytic cell line U937 differentiates into macrophages in response to a variety of agents. Several genes including the cyclin-dependent kinase inhibitor p21waf1/cip1 and the homeobox gene transcription factor HOXA10 are induced at the onset of differentiation. Ectopic expression of either gene results in U937 differentiation. In this paper, we describe a mechanism by which p21 and HOXA10 may act in concert, where HOXA10 can bind directly to the p21 promoter and, together with its trimeric partners PBX1 and MEIS1, activate p21 transcription, resulting in cell cycle arrest and differentiation. These experiments for the first time identify p21 as a selective target for a HOX protein and link the differentiative properties of a transcription factor and a cell cycle inhibitor.

Keywords

Footnotes

  • 1 Corresponding author.

  • E-MAIL l-freedman{at}ski.mskcc.org; FAX (212) 717-3298.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.817100.

    • Received May 4, 2000.
    • Accepted September 1, 2000.
| Table of Contents

G&D Most Read

View all ...

follow us on twitter

Life Science Alliance